Giardiasis

BMJ. 2016 Oct 27:355:i5369. doi: 10.1136/bmj.i5369.

Authors

Corrado Minetti¹, Rachel M Chalmers², Nick J Beeching³, Chris Probert⁴, Kenneth Lamden⁵

Affiliations

¹ Vector Biology Group, Liverpool School of Tropical Medicine, Liverpool, UK.
² Cryptosporidium Reference Unit, Public Health Wales Microbiology ABM, Singleton Hospital, Swansea, UK.
³ Clinical Sciences Group, Liverpool School of Tropical Medicine, Liverpool, UK.
⁴ Institute of Translational Medicine, University of Liverpool, Liverpool, UK.
⁵ Wingate Medical Centre, Kirkby L33 6YJ, UK kenneth.lamden@gmail.com.

PMID: 27789441
DOI: 10.1136/bmj.i5369

No abstract available

Publication types

Review

MeSH terms

Antiprotozoal Agents / therapeutic use
Asymptomatic Diseases
Giardia
Giardiasis / diagnosis*
Giardiasis / drug therapy
Giardiasis / etiology
Humans
Risk Factors

Substances

Antiprotozoal Agents